Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE SCIENCES   ADCOCK INGRAM
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
ADCOCK INGRAM
Jun-14
SUVEN LIFE SCIENCES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs94317-   
Low Rs45229-   
Sales per share (Unadj.) Rs0.694.2-  
Earnings per share (Unadj.) Rs-5.4-23.7-  
Cash flow per share (Unadj.) Rs-5.1-19.7-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.274.0-  
Shares outstanding (eoy) m218.07168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.82.9 3,862.5%   
Avg P/E ratio x-12.8-11.5 111.4%  
P/CF ratio (eoy) x-13.5-13.9 97.7%  
Price / Book Value ratio x4.03.7 109.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,13146,024 32.9%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1862,889 6.4%   
Avg. sales/employee Rs Th03,705.3-  
Avg. wages/employee Rs Th0672.9-  
Avg. net profit/employee Rs Th0-933.7-  
INCOME DATA
Net Sales Rs m13515,907 0.9%  
Other income Rs m84111 75.8%   
Total revenues Rs m22016,018 1.4%   
Gross profit Rs m-1,196-2,757 43.4%  
Depreciation Rs m65687 9.5%   
Interest Rs m5431 1.2%   
Profit before tax Rs m-1,183-3,763 31.4%   
Minority Interest Rs m0-10 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0235 0.0%   
Profit after tax Rs m-1,183-4,008 29.5%  
Gross profit margin %-883.6-17.3 5,099.1%  
Effective tax rate %0-6.2 0.0%   
Net profit margin %-873.5-25.2 3,466.7%  
BALANCE SHEET DATA
Current assets Rs m3,45511,650 29.7%   
Current liabilities Rs m1,0506,555 16.0%   
Net working cap to sales %1,776.032.0 5,544.4%  
Current ratio x3.31.8 185.1%  
Inventory Days Days3,948111 3,560.0%  
Debtors Days Days218124 175.6%  
Net fixed assets Rs m1,3736,791 20.2%   
Share capital Rs m21874 295.3%   
"Free" reserves Rs m3,5350-   
Net worth Rs m3,75312,485 30.1%   
Long term debt Rs m04,387 0.0%   
Total assets Rs m4,82823,585 20.5%  
Interest coverage x-218.8-7.7 2,830.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x00.7 4.2%   
Return on assets %-24.4-15.2 160.8%  
Return on equity %-31.5-32.1 98.2%  
Return on capital %-31.4-19.8 158.4%  
Exports to sales %40.40-   
Imports to sales %839.80-   
Net fx Rs m-1,0820-   
CASH FLOW
From Operations Rs m-1,0311,358 -76.0%  
From Investments Rs m-2,606-417 625.2%  
From Financial Activity Rs m3,9553,982 99.3%  
Net Cashflow Rs m3174,923 6.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.37 Rs / ZAR

Compare SUVEN LIFE SCIENCES With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE SCIENCES With: VENUS REMEDIES  SYNCOM HEALTHCARE  NATURAL CAPS  SUVEN PHARMACEUTICALS  ALPA LAB  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.